Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institut Claudius Regaud (ICR) is a premier French Comprehensive Cancer Center located in Toulouse and is a founding member of the IUCT-Oncopole. Operating as a private non-profit institution, it integrates specialized oncology care, high-level clinical research, and medical training within the Unicancer network. The institute is particularly recognized for its expertise in radiotherapy, surgical oncology, and the management of complex cancers including breast, gynecological, and head and neck malignancies. ICR serves as a major hub for clinical trials in Europe, acting as both a lead investigator and a promoter for innovative therapeutic studies in collaboration with the pharmaceutical industry and academic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut Claudius Régaud.